Every 10-Q that NeOnc Technologies Holdings, Inc. (NTHI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NTHI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NTHI filings page.
NeOnc Technologies Holdings, Inc. reported a net loss of $23.1 million for the six months ended June 30 2026, compared with $38.0 million a year earlier. Operating expenses were driven by research and development of $3.9 million, legal and professional fees, and stock-based compensation of $8.4 million.
Cash and cash equivalents were $1.97 million at June 30 2026 against total current liabilities of $23.5 million, and the accumulated deficit reached $135.8 million, resulting in a stockholders’ deficit of $18.5 million. Management states that these factors raise substantial doubt about the company’s ability to continue as a going concern for one year from the financial statement issuance date.
To support liquidity, NeOnc raised approximately $15.1 million in gross proceeds from a January 2026 PIPE, issuing 2,093,305 common shares and the same number of warrants at a $9.00 exercise price, and issued $5.0 million of Series A Convertible Preferred Stock, which includes an embedded derivative liability recorded at $1.65 million.
NeOnc Technologies Holdings reported a larger first-quarter net loss while highlighting serious liquidity risks. For the three months ended March 31, 2026, the company generated no revenue and recorded a net loss of $8.8 million, compared with a $32.3 million loss a year earlier. Cash and cash equivalents were just $138,601 against total liabilities of $16.6 million, leaving a stockholders’ deficit of $13.2 million. Management states that existing capital is not sufficient to fund operations for one year from the financial statement issuance date and that this raises substantial doubt about NeOnc’s ability to continue as a going concern. To support operations, the company relied on equity financing, including a January 2026 private placement that brought in about $13.1 million of gross proceeds and sales under an equity purchase agreement.
NeOnc Technologies Holdings (NTHI) filed its Q3 2025 10‑Q, reporting a net loss of $8.6 million for the quarter and $46.6 million year‑to‑date. Operating expenses rose on non‑cash items, including $5.0 million in Q3 share‑based compensation and $25.96 million year‑to‑date. Cash and cash equivalents were $1.51 million at September 30, 2025, with a shareholders’ deficit of $11.81 million and accumulated deficit of $97.23 million. The company stated that these conditions raise substantial doubt about its ability to continue as a going concern.
NeOnc completed its Nasdaq listing in March and received $11.64 million from a private placement after effectiveness. It also drew net proceeds of $3.20 million from an equity purchase agreement (447,527 shares) and issued $4.0 million of convertible notes with a 20% original issue discount, later extended once. Current liabilities include an accrued related‑party advisory fee of $3.68 million and a litigation settlement payable of $4.75 million. NIH grants of $400,000 and about $1.01 million were awarded late in the quarter; no related revenue was recognized.
NeOnc Technologies Holdings, Inc. completed a Nasdaq listing in March 2025 and received $11,644,005 from private placement commitments held in escrow until its registration became effective. For the three and six months ended June 30, 2025, the company reported net losses of $5,680,170 and $38,006,186, respectively, and an accumulated deficit of $88,614,631 at June 30, 2025. Shares outstanding were 19,026,776 at June 30, 2025 (18,090,526 at December 31, 2024). The company has material related-party obligations including an accrued advisory fee balance of $5,882,710 and an unpaid litigation settlement payable of $4,000,000. Financing activity includes bridge and promissory note arrangements with original issue discounts and subsequent issuance of promissory notes totaling $4,000,000 as of August 13, 2025. The filing discloses significant accumulated losses, ongoing financing arrangements, and contingent obligations that affect liquidity.